SEVERE CHRONIC ACTIVE HEPATITIS (AUTOIMMUNE TYPE) MIMICKED BY COINFECTION OF HEPATITIS-C AND HUMAN IMMUNODEFICIENCY VIRUSES

被引:13
作者
BERK, L
SCHALM, SW
HEIJTINK, RA
机构
[1] UNIV ROTTERDAM,HOSP DIJKZIGT D,DEPT INTERNAL MED 2,MOLEWATERPLEIN 40,3015 GD ROTTERDAM,NETHERLANDS
[2] ERASMUS UNIV,DEPT VIROL,3000 DR ROTTERDAM,NETHERLANDS
关键词
D O I
10.1136/gut.32.10.1198
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Severe chronic active hepatitis, defined as the presence of a fivefold increase in serum amino-transferases and a twofold rise in gamma-globulin for at least 10 weeks, is considered a progressive immunological liver disease requiring corticosteroid treatment, particularly when serum autoantibodies and a severe lymphoplasma-cellular periportal infiltrate are found in the liver biopsy specimen. A 38 year old man who fulfilled the criteria for severe chronic active hepatitis is described. His sex, his homosexuality, and the presence of antibodies against HIV, however, led to the suspicion of a coinfection with hepatitis C virus (HCV) rather than autoimmune disease. The rapid and complete response to alpha-interferon treatment and a recently available positive antibody test for HCV supported this view. These findings indicate that a HCV related chronic active hepatitis can present as the severe autoimmune type of chronic active hepatitis. Moreover, as in HBV infection, the response to treatment differs from that of autoimmune severe chronic active hepatitis.
引用
收藏
页码:1198 / 1200
页数:3
相关论文
共 13 条
  • [1] CONTROLLED PROSPECTIVE TRIAL OF CORTICOSTEROID THERAPY IN ACTIVE CHRONIC HEPATITIS
    COOK, GC
    MULLIGAN, R
    SHERLOCK, S
    [J]. QUARTERLY JOURNAL OF MEDICINE, 1971, 40 (158): : 159 - +
  • [2] CZAJA AJ, 1986, CHRONIC ACTIVE HEPAT
  • [3] TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALFA - A MULTICENTER RANDOMIZED, CONTROLLED TRIAL
    DAVIS, GL
    BALART, LA
    SCHIFF, ER
    LINDSAY, K
    BODENHEIMER, HC
    PERRILLO, RP
    CAREY, W
    JACOBSON, IM
    PAYNE, J
    DIENSTAG, JL
    VANTHIEL, DH
    TAMBURRO, C
    LEFKOWITCH, J
    ALBRECHT, J
    MESCHIEVITZ, C
    ORTEGO, TJ
    GIBAS, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) : 1501 - 1506
  • [4] GEALL MG, 1968, GASTROENTEROLOGY, V55, P724
  • [5] GEUBEL AP, 1976, GASTROENTEROLOGY, V71, P444
  • [6] TREATMENT OF CHRONIC NON-A,NON-B HEPATITIS WITH RECOMBINANT HUMAN ALPHA-INTERFERON - A PRELIMINARY-REPORT
    HOOFNAGLE, JH
    MULLEN, KD
    JONES, DB
    RUSTGI, V
    DIBISCEGLIE, A
    PETERS, M
    WAGGONER, JG
    PARK, Y
    JONES, EA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (25) : 1575 - 1578
  • [7] CURRENT CONCEPTS - PRIMARY SCLEROSING CHOLANGITIS
    LARUSSO, NF
    WIESNER, RH
    LUDWIG, J
    MACCARTY, RL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (14) : 899 - 903
  • [8] RAPIDLY PROGRESSIVE NON-A, NON-B HEPATITIS IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    MARTIN, P
    DIBISCEGLIE, AM
    KASSIANIDES, C
    LISKERMELMAN, M
    HOOFNAGLE, JH
    [J]. GASTROENTEROLOGY, 1989, 97 (06) : 1559 - 1561
  • [9] HEPATITIS-C VIRUS-ANTIBODIES IN CHRONIC ACTIVE HEPATITIS - PATHOGENETIC FACTOR OR FALSE-POSITIVE RESULT
    MCFARLANE, IG
    SMITH, HM
    JOHNSON, PJ
    BRAY, GP
    VERGANI, D
    WILLIAMS, R
    [J]. LANCET, 1990, 335 (8692) : 754 - 757
  • [10] MURRAYLYON IM, 1973, LANCET, V1, P735